BioPharm International, January 2012 Issue (PDF)
Therapeutic Vaccines
Auditing by the Numbers
Contract organizations must have highly organized teams and plans to accommodate today's audits.
Here's to a Year of Compromise
The benefits of harmonization may be on industry's wish list, but buying into change is another story.
USAID Moves Global Healthcare Initiatives Forward
Government plans require investment, partnership, and industry collaboration.
The Conception and Production of Conjugate Vaccines Using Recombinant DNA Technology
Recombinant technology can be used to produce conjugate vaccines.
Therapeutic Vaccine Outlook
Has an approval in oncology reignited interest in the recruitment of the immune system in the fight against disease?
Budget Crunch, Political Battles Shape Policy Agenda for Year
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
A 25-Year Retrospective on Separations Technology
This month, we rewind to "Separations Technology Outlook, Part II: Improved Recovery and Greater Purity."
An Overview of Risk Assessment Strategies for Extractables and Leachables
Approaches for risk assessment of extractables and leachables.
Global Economic Woes Overshadow Biotech Industry Advances in 2011
Greater emphasis on focus and efficiency for companies as market demands value in 2012.
Ice Fog as a Means to Induce Uniform Ice Nucleation During Lyophilization (Peer Reviewed)
The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.
Contract Services in 2012
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
